Global Estimates of COVID-19 Morbidity and Mortality: A Cohort Study and Mathematical Model Analysis
- PMID: 41326308
- DOI: 10.1111/irv.70154
Global Estimates of COVID-19 Morbidity and Mortality: A Cohort Study and Mathematical Model Analysis
Abstract
Background: The true extent of the severity and fatality caused by the COVID-19 pandemic remains uncertain. This study provides an approximate estimate of the global disease burden from the pandemic.
Methods: A cohort study followed the Qatari population from the onset of the pandemic to March 18, 2024, to estimate the age-specific incidence rates of severe, critical, and fatal COVID-19, classified according to World Health Organization criteria. A mathematical model then utilized these rates to generate regional and global estimates of COVID-19 severity and fatality.
Results: The incidence rate of any severe, critical, or fatal COVID-19 throughout the pandemic was 1.13 (95% CI: 1.07-1.19) per 1000 person-years, while that of fatal COVID-19 alone was 0.11 (95% CI: 0.09-0.13) per 1000 person-years. Globally, the number of severe, critical, or fatal COVID-19 cases was estimated at 61.9 million (95% UI: 55.0-69.9 million), while the number of fatal COVID-19 cases alone was estimated at 11.3 million (95% UI: 7.8-17.4 million). Both estimates showed large regional variations. Most severe, critical, and fatal COVID-19 cases occurred during the pre-Omicron phase of the pandemic.
Conclusions: The COVID-19 pandemic had a profound global impact on morbidity and mortality, emphasizing the critical need for preparedness for future pandemics.
Keywords: SARS‐CoV‐2; cohort study; epidemiology; fatality; mathematical model; severity.
© 2025 The Author(s). Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.
References
-
- Covid‐19 Excess Mortality Collaborators, “Estimating Excess Mortality due to the COVID‐19 Pandemic: A Systematic Analysis of COVID‐19‐Related Mortality, 2020‐21,” Lancet 399, no. 10334 (2022): 1513–1536.
-
- W. Msemburi, A. Karlinsky, V. Knutson, S. Aleshin‐Guendel, S. Chatterji, and J. Wakefield, “The WHO Estimates of Excess Mortality Associated With the COVID‐19 Pandemic,” Nature 613, no. 7942 (2023): 130–137.
-
- H. H. Ayoub, G. R. Mumtaz, S. Seedat, M. Makhoul, H. Chemaitelly, and L. J. Abu‐Raddad, “Estimates of Global SARS‐CoV‐2 Infection Exposure, Infection Morbidity, and Infection Mortality Rates in 2020,” Glob Epidemiol 3 (2021): 100068.
-
- D. M. Cutler and L. H. Summers, “The COVID‐19 Pandemic and the $16 Trillion Virus,” JAMA 324, no. 15 (2020): 1495–1496.
-
- P. Relan, N. V. Motaze, K. Kothari, et al., “Severity and Outcomes of Omicron Variant of SARS‐CoV‐2 Compared to Delta Variant and Severity of Omicron Sublineages: A Systematic Review and Metanalysis,” BMJ Global Health 8, no. 7 (2023): e012328.
MeSH terms
Grants and funding
- QUCG-CAS-23/24-114/Qatar University
- ARG02-0402-240119/Qatar Research Development and Innovation Council
- Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core
- Ministry of Public Health and Hamad Medical Corporation
- Junior Faculty Transition to Independence Program at Weill Cornell Medicine-Qatar
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
